Clinical Trials Logo

Parturient clinical trials

View clinical trials related to Parturient.

Filter by:
  • None
  • Page 1

NCT ID: NCT04441463 Not yet recruiting - Newborn Clinical Trials

Simultaneous Study of the Serum Tryptase Level of the Mother and the Child During Childbirth (TryPla)

TryPla
Start date: September 2020
Phase: N/A
Study type: Interventional

Currently the neonatal serum level of severals proteins can be used as an indicator of subsequent risk. For example, we plan to explore the neonatal kinetics of tryptase and other immune proteins as potential markers for the risk of postnatal complications, particularly in premature babies. However, today no study has shown whether the tryptase level in the newborn is a reflection of fetal synthesis alone, or that of the mother by possible transplacental passage. There is also no database that has defined normal values for tryptase in cord blood. Our main objective is to determine the correlation between the level of maternal tryptase and that of the newborn in cord blood immediately after birth in order to estimate the transplacental passage of this molecule.

NCT ID: NCT04056403 Recruiting - Parturient Clinical Trials

Ultrasound Evaluation of Labor Epidural

Start date: August 2019
Phase:
Study type: Observational

To compare the labor epidural analgesic (EA) profiles between landmark insertion EA levels which are congruent and ingruent to ultrasound confirmation in lateral decubitus position.

NCT ID: NCT03222414 Terminated - Blood Pressure Clinical Trials

Non-invasive Versus Invasive Blood Pressure Measurement in the Morbidly Obese Parturient With Severe Preeclampsia

Start date: May 1, 2015
Phase: N/A
Study type: Interventional

The study will compare agreement of invasive blood pressure measurements with non-invasive blood pressure measurements measured with a conical blood pressure and large standard upper arm rectangular cuff in morbidly obese severely hypertensive (systolic blood pressure > 160 mmHg) parturients.

NCT ID: NCT01943565 Not yet recruiting - Healthy Clinical Trials

Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study

Start date: October 2013
Phase: Phase 4
Study type: Interventional

Pain relief after cesarean delivery can be provided in a few ways. Most commonly, certain medications called opioids, such as morphine, are given through the vein or into the muscle. However, a more effective way to give pain relief with fewer side effects (such as nausea and slowing your breathing) is to give opioids in the spinal space as part of the medications given for a cesarean delivery. For many years, the opioid of choice was morphine due to its long anesthetic effect and acceptable side effect profile. A nation-wide disruption in the supply of preservative-free morphine has made it necessary to look for alternatives. Many institutions worldwide have used another opioid, called hydromorphone, in the spinal space for over a decade. This drug has a very good safety and side effect profile and has been used at our institution for more than a year. Of interest, while a number of different doses of hydromorphone have been used, there have been very few studies to evaluate the best dose for providing good pain relief with minimal side effects. The goal of this study is to find the best dose of spinal hydromorphone for women undergoing cesarean delivery.